Navigation Links
New drugs for resistant forms of TB

An international meeting on breathing disorders in Paris discussed the ongoing research on development of new drugs against tuberculosis. //There is a need to revamp the more than a century old test that takes a long time for detection and drugs to which the strains of TB have become resistant.

According to Nils Billo, one of the organisers of the 37th world congress of the Union for breathing health and executive director of the Paris-based International Union Against Tuberculosis and Breathing Disorders (UNION), 2 new methods of development of new drugs against TB are being discussed.

"During the Paris conference, we will witness the presentation of the research work conducted by two teams. The response we get from these works is that which sustains the hope of getting new drugs against the disease in the next few years," Billo said.

The multi-drug resistant TB that is resistant to the antibiotics isoniazid and rifampin has been a major cause of concern to the health officials for more than a decade.

He said, "The new drugs, if developed, would take into account the resistance of tuberculosis to the already existing antibiotics, their prices would be affordable even in developing countries."

"The making of new drugs will arguably be a decisive element in the fight against TB but this fight could be won only if southern countries have significant human resources on the fight against tuberculosis," Billo said.

Tuberculosis is the world's deadliest curable infectious respiratory disease that spreads by coughing and sneezing. According to the World Health Organization, it claims 1.7 million lives every year.

Asthma and tobacco addiction will also be discussed in the conference attended by over 2,000 participants from 130 countries.
GYT
'"/>




Page: 1

Related medicine news :

1. Cancer drugs in development nearly doubled since 1995
2. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
3. African HIV strains more resistant to anti HIV drugs
4. Right drugs drastically cut stroke risk
5. Relating heart protection and antihypertensive drugs
6. Enzyme may be target for obesity drugs
7. New HIV cases resist drugs
8. Relief to pregnant women using fertility drugs
9. AIDS drugs linked to heart attack risk
10. FDA debates status of decongestant drugs
11. Status of some prescription drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is ... in Building 2. The clinic is the group’s second in New Braunfels and 22nd ... company’s second New Braunfels location brings things full circle for the group, “It’s crazy ...
(Date:3/23/2017)... ... ... The IoT (Internet of Things) is revolutionizing the way the world operates. ... individual consumers alike. Laboratories can maximize their profit margin by increasing throughput. ... to $11 trillion dollars by the year 2025. McKinsey expects the IoT to have ...
(Date:3/23/2017)... York, NY (PRWEB) , ... March 23, 2017 , ... 82% of adults are unaware ... 3 kids do not brush their teeth the minimum two times a day that dentists ... with students missing 51 million hours of school and adults missing 164 million hours of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March is National Kidney Month – the perfect ... comes to maintaining good health. Every day, two kidneys filter about 120 to 150 ... of your blood, eliminating waste, regulating fluid levels and blood pressure, supporting bone health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company announced ... The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive ... that have excellent programs for the delivery and improvement of disease management and ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Prima BioMed has presented encouraging early signs ... combination with Keytruda, with one of the six melanoma ... response. Recruitment in the second cohort is complete and ... by Q317. Preliminary efficacy data from the 15-patient, run-in ... mid-year (recruitment in the 226-patient Phase IIb component is ...
(Date:3/23/2017)... , March 23, 2017 ... consolidated vendor landscape with the top five players ... in 2015. These companies are Stryker Sustainability Solutions, ... Health Services, Inc., and VANGUARD AG. Despite the ... devices market is witnessing the prevalence of fierce ...
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
Breaking Medicine Technology: